Patents/Inventors

William Olson

Yorktown Heights, NYUS33 patents

29 Patents

US126054732026
Methods for Making Radiolabeled Anti-met Binding Proteins
REGENERON PHARMACEUTICALS, Inc.
0 cites
US125891012026
Cyclodextrin Protein Drug Conjugates
Regeneron Pharmaceuticals, Inc.
0 cites
US125839392026
Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US125646512026
Radiolabeled Anti-pd-l1 Antibodies for Immuno-pet Imaging
REGENERON PHARMACEUTICALS, Inc.
0 cites
US124974602025
Anti-msr1 Antibodies and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US124484352025
Anti-tmprss6 Antibodies and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US123771592025
Steroids and Protein-conjugates Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US123381992025
Bis-octahydrophenanthrene Carboxamides and Protein Conjugates Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US123311272025
Therapeutic Uses of Anti-gitr Antibodies
REGENERON PHARMACEUTICALS, Inc.
0 cites
US122801242025
Antibody-drug Conjugates Comprising GLP1 Peptidomimetics and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US122514402025
Anti-sars-cov-2-spike Glycoprotein Antibodies and Antigen-binding Fragments
Regeneron Pharmaceuticals, Inc.
0 cites
US122091802025
Bis-octahydrophenanthrene Carboxamide Derivatives and Protein Conjugates Thereof for Use as LXR Agonists
REGENERON PHARMACEUTICALS, Inc.
0 cites
US121520672024
Human Antibodies to Ebola Virus Glycoprotein
Regeneron Pharmaceuticals, Inc.
0 cites
US121448642024
Tubulysins and Protein-tubulysin Conjugates
Regeneron Pharmaceuticals, Inc.
0 cites
US121152162024
Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US121039602024
VEGF Traps and Mini-traps and Methods for Treating Ocular Disorders and Cancer
REGENERON PHARMACEUTICALS, Inc.
0 cites
US120775872024
Anti-cd8 Antibodies and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US120604282024
Anti-il36r Antibodies
Regeneron Pharmaceuticals, Inc.
0 cites
US120535342024
Radiolabeled Anti-pd-l1 Antibodies for Immuno-pet Imaging
Regeneron Pharmaceuticals, Inc.
0 cites
US120245702024
Anti-ctla-4 Antibodies and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US119589102024
Bispecific Antigen Binding Molecules That Bind HER2, and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US118966822024
Radiolabeled MET Binding Proteins for Immuno-pet Imaging and Methods of Use Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117866032023
Optimized Transglutaminase Site-specific Antibody Conjugation
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117878672023
Anti-gitr Antibodies and Uses Thereof
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117809072023
Human Antibodies to Influenza Hemagglutinin
REGENERON PHARMACEUTICALS, Inc.
0 cites
US117607752023
Steroids and Protein-conjugates Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US117320302023
Anti-sars-cov-2-spike Glycoprotein Antibodies and Antigen-binding Fragments
Regeneron Pharmaceuticals, Inc.
0 cites
US115714822023
Human Antibodies to S. Aureus Hemolysin a Toxin
Regeneron Pharmaceuticals, Inc.
0 cites
US115595762023
Anti-human Papillomavirus (HPV) Antigen-binding Proteins and Methods of Use Thereof
Regeneran Pharmaceuticals, Inc.
0 cites